41 – 50 of 662
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Olfactory dysfunction and amyloid-positivity in Parkinson’s disease—longitudinal analysis of cognitive decline and cerebrospinal fluid markers
- Contribution to journal › Article
-
Mark
Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome
- Contribution to journal › Article
-
Mark
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias : An international multi-center study
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid and brain positron emission tomography measures of synaptic vesicle glycoprotein 2A : Biomarkers of synaptic density in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Updated Appropriate Use Criteria for Amyloid and Tau PET : A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
- Contribution to journal › Article
-
Mark
Influence of ethnicity on the diagnostic accuracy of plasma p-tau217 for the identification of Alzheimer's disease : A consecutive mixed memory clinic cohort study
- Contribution to journal › Article
-
Mark
Predictive Value of Plasma Biomarkers in Tau-PET Transitions
- Contribution to journal › Article
-
Mark
Cell-weighted polygenic risk scores are associated with β-amyloid and tau biomarkers in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Shared and disease-specific pathways in frontotemporal dementia and Alzheimer’s and Parkinson’s diseases
- Contribution to journal › Article
-
Mark
Locus coeruleus-entorhinal cortex tract integrity is linked to plasma tau and glial fibrillary acidic protein
- Contribution to journal › Article
